Automata

Automata

Private
London, EnglandHealthcare & Life Scienceshttps://automata.tech

Last Round

Series C

Jan 29, 2026

Est. Valuation

$1.95M

Total Funding Raised

$142.73M

Company Overview

Automata is a London-based technology company that provides automation solutions for the life sciences industry. Founded in 2015 by two architects, the company initially focused on affordable robotics before concentrating on transforming laboratory workflows. Automata develops the LINQ platform, a comprehensive solution combining robotic hardware and cloud-based software to fully automate lab processes. This enables scientific organizations in diagnostics, drug discovery, and biotech to increase throughput, reduce errors, and accelerate innovation. The company is venture-backed, having raised significant funding, including a $40 million round in October 2023, to support its expansion in the UK, Europe, and the US.

Sector

Healthcare & Life Sciences

Verticals

Workflow Automation, Biotech Equipment, Industrial Robotics

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Subscription SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

lab automationlab automation platformlife sciences automationlab roboticsworkflow orchestration softwarelab operating systemAI-ready labshardware and software platformrobotic armNGS automationnext-generation sequencingNGSclinical diagnosticsinstrument integrationpathology automationOEM-agnostic automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Automata Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Automata Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series CJan 29, 2026
Series B ExtensionOct 3, 2023
Series BFeb 22, 2022
Series AMar 20, 2019
GrantMar 29, 2017
Grant
Feb 24, 2016

Key People

Founding team and executive leadership

Mostafa Elsayed

Co Founder CEO

Founding Team

Jennifer Howson

Chief Financial Officer

Executive Team

Automata Investors

Notable investors and investment history

InvestorRounds
Innovate UKSeed, Grant
Tru Arrow PartnersSeries C
LocalGlobeSeries A
Firstminute CapitalSeries A
Latitude VenturesSeries B
Aldea VenturesSeries B Extension
ABBSeries A, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 10, 2026

    Murali Venkatesan joins the board of directors.

  • Oct 10, 2025

    Trusted automation partner for leading NHS trusts.

Automata Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Automata Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Automata's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon, England
Employee Range181
Year Founded2015
Last FundingJan 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.